The efficiency of treatment of diffuse stomach cancer can be improved by using a complex phytoadaptogen. In groups receiving phytoadaptogen, the level of tumor marker CA 19-9 decreased and the mean life span of patients increased by 2.5 times. The drug exhibited immunomodulating (including interferonogenic and adhesiogenic), antioxidant, and hormonemodulating effects.
Similar content being viewed by others
References
V. N. Anisimov, Uspekhi Gerontol., No. 3, 275-287 (2002).
O. A. Bocharova and R. V. Karpova, Ros. Bioterapevt. Zh., No. 3, 55–60 (2006).
M. I. Davydov, S. N. Nered, and A. A. Klimenkov, Vestn. Rossiisk. Onkol. Nauch. Tsentra Rossiisk. Akad. Med. Nauk, No. 3, 10–16 (2004).
F. I. Ershov, The Interferon System in Health and Disease [in Russian], Moscow (1996).
A. S. Attele, J. A. Wu, and C. S. Yuan, Biochem. Pharmacol., 58, No. 11, 1685–1693 (1999).
S. Ebrahim and A. Kalache, Epidemiology in Old Age, L., (1996).
H. Kaneko and K. Nakanishi, J. Pharmacol. Sci., 95, No. 2, 158–162 (2004).
N. D. Kim, Y. R. Pokharel, and K. W. Kang, Pharmazie, 62, No. 12, 933–936 (2007).
S. W. Kim, H. Y. Kwon, D. W. Chi, et al., Biochem. Pharmacol., 65, No. 1, 75–82 (2003).
Y. J. Kim, H. C. Kwon, H. Ko, et al., Biol. Pharm. Bull., 31, No. 5, 826–830 (2008).
H. Kuribara, H. Tomioka, R. Takahashi, et al., Phytother. Res., 18, No. 2, 173–176 (2004).
P. Y. Yue, D. Y. Wong, P. K. Wu, et al., Biochem. Pharmacol., 72, No. 4, 437–445 (2006).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 148, No. 7, pp. 96-99, July, 2009
Rights and permissions
About this article
Cite this article
Bocharova, O.A., Davydov, M.I., Klimenkov, A.A. et al. Prospects of Using Phytoadaptogen in the Treatment of Diffuse Stomach Cancer. Bull Exp Biol Med 148, 82–85 (2009). https://doi.org/10.1007/s10517-009-0652-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-009-0652-6